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ABSTRACT
Objective: Comparison of the incidence and case fatality of early-onset group B streptococcus sepsis
and sepsis caused by other pathogens in neonates after change of management of intrauterine
infection.
Methods: All infants delivered from 1988 through 1997 at a gestational age -> 24 weeks with a
birth weight -> 500 gram without lethal congenital abnormalities were eligible for inclusion. Infants
delivered by cesarean section before the onset of labor or rupture of membranes were excluded.
During the first period (1988-1991) intrauterine infection was diagnosed by a temperature > 38C,
during the second period (1992-1997) this diagnosis was made at a lower temperature (-> 37.8C)
or by fetal tachycardia -> 160/min. Treatment of intrauterine infection was similar during both
periods with 3 x 2 gram amoxicillin and 1 x 240 mg gentamicin every 24 hours intravenously during
labor. Prophylactic treatment during labor was only given to women with a history of an earlier
infant with early-onset group B streptococcus sepsis.
Results: During the first period 6,103 infants were included, during the second period 8,504.
Intrauterine infection was diagnosed and treated more often in the second period (7.1% vs. 2.6%).
The incidence of early-onset group B streptococcus sepsis was significantly lower in the second
period than in the first period [0.2% vs. 0.4%; OR 0.5 (0.3-0.9)] and survival without disability
higher [80% vs. 52%; OR 4.5 (1.4-16.5)]. However, in both periods the overall incidence ofneonatal
sepsis (3.6% vs. 3.5%) and overall mortality because of sepsis (14.3% vs.13.1%) were similar.
Conclusions: Although the early detection of clinical signs of intrauterine infection might have
been effective for the prevention of serious sequelae of early-onset group B streptococcus sepsis the
overall incidence and mortality from neonatal sepsis remained unchanged. Evaluation ofpreventive
measures for early-onset group B streptococcus sepsis should always take the incidence of neonatal
sepsis caused by other pathogens into account. Infect. Dis. Obstet. Gynecol. 8:143-150, 2000.
(C) 2000 Wiley-Liss, Inc.
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he optimum clinical strategy to prevent neona-
tal early-onset group B streptococcus infection
has not yet been established. Although it is gener-
ally assumed that penicillin during labor prevents
nearly all cases of early-onset group B streptococ-
cus infection, conclusive statistical evidence is not
available.
Three analysesz-4 of cost-effectiveness for dif-
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ferent preventive strategies used comparable risk
estimates but different cost calculations and
reached different conclusions. Two studies3,4
stated that universal recto-vaginal culture at 26 to
28 weeks for group B streptococcus (GBS) and in-
trapartum treatment of culture-positive high-risk
patients in labor was cost effective. A third studyz
questioned this and concluded that presently ei-
ther universal treatment during labor, or treatment
based on risk factors, or treatment based on pre-
term delivery and 36-week culture stats would be
the most effective strategies.
A disadvantage of decision analysis is that the
influence of contributing factors is based on re-
search performed some time earlier, while the
weight of these factors may well be modified by
other changes of management than antibiotic pro-
phylaxis or by technical improvements in neonatal
care. Ideally a comparison of different strategies for
prevention of early-onset GBS infection should be
performed by a randomized trial. Unfortunately,
such studies are not feasible due to the low inci-
dence of early-onset GBS infection and conse-
quently the extremely large number of patients
that would be required.5 Furthermore, most stud-
ies of preventive strategies for early-onset GBS in-
fection do not take other causes of neonatal sepsis
into account. It is not known presently whether the
incidence of neonatal sepsis caused by other organ-
isms is influenced positively or negatively by these
strategies. The endpoint of our study is, therefore,
not only early-onset GBS infection but also neona-
tal sepsis of other origin. The purpose of the study
is to evaluate a change of management regarding
the diagnosis and treatment of women with early
signs of intrauterine infection during labor. The
hypothesis of this new strategy was that most seri-
ous sequelae and death would result from intra-
uterine onset of early-onset GBS infection, while
colonization and onset of infection after delivery
would be recognized more easily and could there-
fore be treated in a more timely manner.
SUBJECTS AND METHODS
All infants delivered in our tertiary care center from
January 1988 through December 1997 at a gesta-
tional age >- 24 weeks with a birth weight >- 500
gram without lethal congenital abnormalities were
eligible for inclusion in the study. Infants delivered
by cesarean section before the onset of labor or
rupture of membranes were excluded. Gestational
age was calculated by the last menstrual period and
early ultrasonographic measuremen, if available.
During the first study period (1988 through
1991) no special preventive measures for early-
onset GBS infection were taken. Intrauterine in-
fection during labor was diagnosed by rectal tem-
perature of > 38.0C on repeated measurement
within 30-60 minutes.
During the second period (1992 through 1997)
management was based on the hypothesis that
signs of intrauterine infection were the major risk
factor for early-onset GBS infection. The criteria
for suspected intrauterine infection were rectal
temperature >- 37.8C observed twice within 30-60
minutes or fetal tachycardia >- 160/rain.
Treatment for intrauterine infection was similar
in both periods with amoxicillin 3 x 2 gram/24 hr
and gentamicin x 240 mg/24 hr i.v. until delivery.
In case of allergy to penicillin erythromycin 4 x
gram/24 hr was administered. Prophylactic penicil-
lin during labor was administered only to women
with a history of early-onset GBS infection in an
earlier infant. Prelabor rupture of membranes was
managed expectantly without the use of prophy-
lactic antibiotics. Once antibiotic treatment was
started during labor, treatment was continued in
the infant(s).
Outcome criteria were neonatal early-onset GBS
infection, death or abnormal development of in-
fants after early-onset GBS infection, neonatal sep-
sis caused by other pathogens, and perinatal mor-
tality. The diagnosis of early-onset GBS infection
was confirmed in all cases by a positive culture
from material that normally should be sterile
(blood, cerebrospinal fluid, or tissue obtained at
autopsy). Neonatal sepsis caused by E. coli, Staph-
ylococcus species, and other pathogens was diag-
nosed similarly. Infants with sepsis diagnosed by
clinical signs and leukocyte count without confir-
mation by microbiology were classified separately.
Classification of neonatal morbidity was performed
by one neonatologist throughout the study period.
Postnatal mortality included all liveborn infants
who died before discharge from hospital, irrespec-
tive of their age. Follow-up was continued for at
least two years in infants after early-onset GBS.
Surviving infants were clinically screened and clas-
sified as normal or suspected of disability or handi-
cap according to the WHO classification.6
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TABLE I. Demographic and perinatal details of the study population
Period
(1988-1991)
Period II
(1992-1997)
Number of women 5833
Maternal age (yr) 29 (12-46)
Caucasian 3280 (56.2)
Primipara 2817 (48.3)
Multiple pregnancy 247 (4.2)
Duration of labor (hr) 8 (0-115)
Duration of ruptured membranes (hr) 4 (0-2281)
Corticosteroids > 24 hr 341 (5.8)
Intrauterine infection during labor 150 (2.6)
Gestational age at delivery (wk) 40 (24-44)
Number of infants 6103
Birth weight (gm) 3200 (515-5320)
Sex male 3189 (52.3)
Stillborn 20 (0.3)
Neonatal mortality < 4 wk 114 (I.9)
Late mortality 4 wk-I yr 6 (0. I)
8118
29 (I 2-50)
3984 (49. I)
3976 (49.0)
368 (4.5)
8 (0-8)
4 (0-2615)
507 (6.2)
578 (7. I)
40 (24-44)
8504
3200 (500-6095)
4392 (51.6)
2 (0.2)
139 (I .6)
9(0.1)
aValues are given as median (range) or number (percentage).
bManteI-Haenszel Chi-square, P < 0.05.
The incidence of sepsis caused by GBS and
other pathogens and perinatal mortality were com-
pared between periods by univariate analysis. Sta-
tistical analysis included the Mantel-Haenszel
Chi-square test for discrete variables. Odds ratios
(OR) are presented with 95% confidence limits
comparing period II versus period I. For continu-
ous variables the two-sample t-test or the Wilcoxon
rank-sum test were used. Statistical significance
was considered at P < 0.05. Further calculation was
performed by stepwise multivariate logistic regres-
sion analysis with early-onset GBS infection, dis-
ability/handicap or death by early-onset GBS infec-
tion and sepsis by other pathogens as dependent
variables. Independent variables evaluated in the
analysis were study period (second vs. first), mater-
nal age (< 20, 20-34, and -> 35 years), Caucasian
versus non-Caucasian descent, multipara versus
nullipara, multi-fetal gestation versus single gesta-
tion, diabetes (gestational, grade 2 and 1), cortico-
steroids for neonatal lung maturation before pre-
term labor, duration of ruptured membranes (< 12
hr, 12-17 hr, 18-23 hr, and -> 24 hr), meconium
stained amnionic fluid, duration of labor (< 12 hr, ->
12 hr), augmentation of labor with oxytocin, dura-
tion of second stage (< 0.5 hr, 0.5-1 hr, and -> hr),
intrauterine infection during labor, gestational age
at delivery [early preterm (24-29 weeks), preterm
(30-36 weeks) and term (-> 37 weeks)], birth
weight (500-1499 gram, 1500-2499 gram, and ->
2500 gram), birth weight < 10th percentile of the
Amsterdam birth weight chart,7 presentation at
birth (cephalic vs. other), and gender (female vs.
male). The stepwise logistic regression analysis was
performed with BMDP statistical software (Los
Angeles, CA). The analysis was started with all
variables included in the model. Terms were re-
moved or re-entered at each step by maximum
likelihood method. The convergence criterion for
the likelihood function and for the parameters was
set at 0.0005.
RESULTS
During the first period 6,103 infants delivered by
5,833 women were included; during the second pe-
riod 8,504 infants delivered by 8,118 women. Ma-
ternal and neonatal characteristics were comparable
between both periods (Table 1). The incidence of
diagnosed intrauterine infection during labor was
significantly higher in the second period (7.1%)
than in the first period (2.6%) [OR 2.9 (2.4-3.5)],
demonstrating the effect of the change of defini-
tion.
Table 2 demonstrates differences of the inci-
dence of early-onset GBS sepsis and sepsis caused
by other pathogens between both periods, subdi-
vided for gestational age. The incidence of early-
onset GBS infection was significantly lower during
the second period (0.2%) than during the first pe-
riod (0.4%) [OR 0.5 (0.3-0.9)]. Case fatality and
total mortality from early-onset GBS infection were
lower during the second period [OR 0.4 (0.1-1.3)
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TABLE 2. Gestational age, occurrence of early-onset group B streptococcus (EOGBS) sepsis, sepsis by other
pathogens, and mortality of infants delivered during period and during period II
Gestational age Period 1988-1991 Period II (1992-1997)
at delivery N (%) Mortality N (%) Mortality
OR (95% CI) of sepsis
Period II vs. Period
All 397 II 6 (29.2) 512 149 (29. I)
24-29 wk EOGBS sepsis 9 (2.3) 4 (44.4) 4 (0.8) 3 (75.0) 0.34 (0. I-I .2)
Sepsis other pathogen 122 (30.7) 16 (13.1) 192 (37.5) 32 (16.7) 1.35 (I.0-1.8)
All 816 16 (2.0) II 14 12 (I.I)
30-36 wk EOGBS sepsis 10 (I.2) 4 (40.0) 8 (0.7) 0 (--) 0.58 (0.2-1.6)
Sepsis other pathogen 55 (6.7) 3 (5.5) 66 (5.9) 4 (6. I) 0.87 (0.6-1.3)
All 4890 8 (0.2) 6878 8 (0. I)
->37 wk EOGBS sepsis 8 (0.2) 2 (25.0) 8 (0.1) 0 (--) 0.71 (0.2-2.1)
Sepsis other pathogen 14 (0.3) 1(7.1) 16 (0.2) (6.3) 0.81 (0.4-1.8)
All 6103 140 (2.3) 8504 169 (2.0)
Total EOGBS sepsis 27 (0.4) 10 (37.0) 20 (0.2) 3 (I 5.0) 0.53 (0.3-0.9)
Sepsis other pathogen 191 (3. I) 20 (10.5) 274 (3.2) 37 (I 3.5) 1.03 (0.8-1.3)
aValues are given as numbers (percentage) or univariate odds ratio (OR) with 95% confidence interval (CI).
bManteI-Haenszel Chi-square, P < 0.05.
and OR 0.2 (0.1-0.8)]. Three infants with early-
onset GBS infection in period and one in period
II were suspected of disability or handicap. Sur-
vival without disability/handicap after early-onset
GBS infection was higher in the second period [OR
4.5 (1.4-16.5)]. The incidence and outcome of
early-onset GBS infection for each year of the
study is shown in Fig. 1.
The incidence of neonatal sepsis and the pro-
portion of infants with early-onset GBS infection
were strongly influenced by gestational age (test
for linear trend, P < 0.0001) (Table 2). In the sec-
ond period GBS was the causative organism of sep-
sis in 4 of 196 (2%) of early preterm infants with
sepsis, in 8 of 74 (11%) of late preterm infants, and
in 8 of 24 (33%) of term infants, while these figures
were 9/131 (7%), 10/65 (15%), and 8/22 (36%), re-
spectively during the first period.
The incidence of sepsis caused by other patho-
gens was significantly higher during the second pe-
riod in early preterm infants [OR 1.35(1.0-1.8)],
although the overall incidence was not significantly
different between both periods [OR 1.0 (0.8-1.3)]
and case fatality [OR 1.3 (0.7-2.5)] and mortality
[OR 1.3 (0.7-2.4)] due to sepsis by other pathogens
were similar. The total incidence of sepsis was
3.6% during the first and 3.5% during the second
study period [OR 1.0 (0.9-1.2)], and case fatality
[OR 1.0 (0.6-1.7)] and mortality by sepsis [OR 1.0
(0.6-1.6)] were comparable between periods.
Table 3 subdivides all infants with sepsis for
different pathogens. The incidence of sepsis
2
normal
dead or disabled handicapped
0
88 89 90 91 92 93 94 95 96 97
Year
Fig. I. The incidence of early-onset group B streptococ-
cus sepsis in each year of the study period. Infants who
recovered and infants who died or remained disabled/
handicapped are presented separately.
caused by E. coli was similar between periods,
while sepsis by Staphylococcus species and by other
pathogens was more frequent during the second
period. The number of infants with sepsis diag-
nosed by clinical signs only, without bacteriological
confirmation, was lower in the second period.
Table 4 shows the duration of admission of sur-
viving infants to the neonatal intensive care unit
and high care unit. The duration of admission was
comparable between infants with early-onset GBS
infection and the remaining infants when gesta-
tional age at delivery was < 37 weeks. In term in-
fants a significant difference of the duration of ad-
146 INFECTIOUS DISEASES IN OBSTETRICS AND GYNECOLOGYTREATMENT OF UTERINE INFECTION WOLF ET AL.
TABLE 3. The number and case fatality of all infants in both periods classified as having sepsis caused by group
B streptococcus (GBS), Staphylococcus species. Escherichia coli, other pathogens, and infants with clinical sepsis
without bacteriological confirmation
Period 1988-1991
n (%) Case fatality (%) n (%)
Period II 199 I-1997)
Case fatality (%)
All infants 6103 114 (I.9) 8504
Neonatal sepsis 218 (3.6) 30 (I 3.8) 294 (3,5)
GBS 27 (0.4) 10 (37.0) 20 (0.2)
Staphylococcus 36 (0.6) (2.8) 90 (I. I)
E. coli 8 (0. I) 4 (50.0) 20 (0.2)
Other pathogens 16 (0.3) 5 (31.3) 46 (0.5)
Clinical sepsis 131 (2. I) 10 (7.6) 118 (I.4)
139 (I.6)
40 (I 3.6)
3 (5.0)
5 (5.6)
5 (5.0)
3 (8.3)
14(11.9)
a’b’c’dManteI-Haenszel Chi-square, P < 0.05.
TABLE 4. Duration of neonatal intensive and high
care for surviving infants according to gestational
age, occurrence of early onset group B
streptococcus (EOGBS) sepsis, sepsis by other
pathogens, and period
Hospital days
Gestational age Period Period II
at delivery (I 988-199 I) (1992-1997)
EOGBS sepsis 37 (8-64) 10 (4-25)
24-36 wk Sepsis other pathogen 36 (7-143) 45 (5-154)
Other infants 8 (0-192) 6 (0-130)
EOGBS sepsis 13 (6-26) 9 (4-16)
_>37 wk Sepsis other pathogen 8 (4-33) 12 (5-26)
Other infants 0 (0-99) 0 (0-95)
aValues are given as median (range).
b’c’dWilcoxon rank-sum test P < 0.05.
mission was observed between infants with early-
onset GBS infection and the remaining infants.
Furthermore, duration of admission of preterm in-
fants with early-onset GBS sepsis was significantly
shorter during the second period.
The results of the multivariate regression analy-
sis of those factors that contributed significantly to
the predicting model for early-onset GBS infection,
for death or disability/handicap by early-onset GBS
infection, and for sepsis caused by other pathogens
are shown in Table 5. The factors that had signifi-
cant influence on the incidence of early-onset GBS
infection were study period (second < first period),
ruptured membranes (18-23 hr > 0-18 hr or -->- 24
hr), intrauterine infection during labor and gesta-
tional age (early prcterm > preterm > term). The
only significant factors influencing death or disabil-
ity/handicap by early-onset GBS infection were
study period and gestational age. Risk factors for
sepsis caused by other pathogens differed from
those for early-onset GBS infection: early preterm
gestational age was an extremely strong risk factor,
intrauterine infection during labor and birth weight
< 10th percentile were of minor importance, while
study period and duration of ruptured membranes
did not influence the model.
DISCUSSION
Although group B streptococcus infection is gener-
ally presented as the leading bacterial cause of dis-
ease and death among newborns, this statement
applied only to term infants in our study popula-
tion. Group B streptococcus was the causal patho-
gen in approximately 35% of the term infants with
sepsis but only in 7% of all preterm infants with
sepsis. Nevertheless, prematurity was a risk factor:
66% of all infants with early-onset GBS infection
were delivered preterm.
The most important factor influencing the inci-
dence of early-onset GBS sepsis is maternal carrier
rate. This figure varies largely from 4% to 40%
(usually 20-30%), depending on ethnic origin, cul-
ture site, and the use of selective culture media.8 In
the Netherlands a carrier rate during labor of 19%
was reported by selective culture of rectum and
introitus.9 In our own hospital in 1992 GBS was
cultured selectively from rectum and introitus in 41
(27%) of 150 women during labor. Carrier rate in
the Netherlands seems to be comparable to many
other countries.
The incidence of early onset GBS sepsis is 0.7-
3.7/1,000, depending on geographic area.8 The in-
cidence in our population is rather high compared
to this figure due to the high incidence of preterm
deliveries (19%) in our tertiary care center as a re-
sult of the referral system in the Netherlands.
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TABLE 5. Odds ratio with 95% confidence limit for early-onset group B streptococcus (EOGBS) sepsis, death
or disability/handicap by early-onset group B streptococcus sepsis, and sepsis caused by other pathogens,
calculated by the final step of stepwise multivariate logistic analysis
Death or disability/handicap Sepsis caused by
EOGBS sepsis by EOGBS sepsis other pathogens
Period 0.5 (0.3-0.8) 0.2 (0. I-0.7)
Multipara 0.6 (0.3-1.2) 0.8 (0.7-1.0)
Multiple pregnancy 0.2 (0. I-0.7)
Intrauterine infection 3.3 (I.6-6.8) 2.3 (0.7-7.7) 1.4 (I. I-I .8)
Ruptured membranes
<12 hr
12-17 hr 1.0 (0.2-4.6)
18-23 hr 6.6 (2.7-16.4)
->24 hr 2.5 (I.2-5.1)
Gestational age
->37 wk
30-36 wk 6.3 (3.1-13.0) 7.9 (I.8-35.6) 26.3 (17.6-39.4)
24-29 wk II. (4.8-25.9) 51.3 (I 3.4-196) 205 (I 39-304)
Birth weight < pl0 0.4 (0.1-1.6) 1.4 (I.0-2.0)
Gender female vs. male 0.7 (0.4-1.2) 0.5 (0.2-1.4)
aFactors marked with did not contribute significantly to the model.
The extensive literature concerning preventive
strategies for neonatal early-onset GBS sepsis was
well summarized in a Centers for Disease Control
(CDC) recommendation in 1996.1 Nine published
controlled or randomized studies regarding the ef-
ficacy of intrapartum chemoprophylaxis were de-
scribed, indicating a reduction of neonatal GBS
colonization and neonatal early-onset GBS disease.
Seven of these studies were accepted by Allen et
al. 11 for meta-analysis. The pooled odds ratio for
reduction of early-onset GBS infection was 0.033
(95% confidence interval 0.0013-0.17) after intra-
partum prophylaxis with penicillin. However,
Ohlsson et al. critically appraised the literature
and excluded five trials because of duplicate pub-
lication, randomization violation, or retrospective
data collection. Three of the remaining four trials
showed a significant reduction of neonatal group B
streptococcal colonization with intrapartum chemo-
prophylaxis. Although a trend toward a reduction of
early-onset GBS infection was reported by these
three studies, each lacked the power to reach sta-
tistical significance. Ohlsson et al. argued that a
meta-analysis was inappropriate due to the hetero-
geneity of therapeutic interventions and flaws in
trial method; and they concluded that intrapartum
chemoprophylaxis to reduce early-onset GBS in-
fection was not supported by conclusive evidence.
Notwithstanding this, the general opinion is that
intrapartum chemoprophylaxis is effective and sev-
eral preventive strategies have been proposed by
professional organizations. 1,1z-14 In 1996, the
CDC developed preventive guidelines in conjunc-
tion with experts from relevant disciplines and rep-
resentatives from professional organizations. They
advised that obstetric care practitioners should
adopt a strategy for the prevention of early-onset
GBS infection and that, presently, prophylaxis
based on risk factors or based on preterm delivery
and 36-week culture status would be most appro-
priate. Universal prophylaxis was disclaimed be-
cause of risk for the emergence of antimicrobial-
resistant organisms. Since then substantially more
hospitals have adopted preventive policies and sur-
veillance data have revealed a decrease in the in-
cidence of early-onset GBS infection, ls,16
Rouse et al.z performed an extensive decision
analysis evaluating cost-effectiveness of 19 differ-
ent strategies. They estimated the probability that
a pregnant woman would be colonized with GBS as
186:1,000. The probability that a colonized gravida
who did not receive intrapartum penicillin would
give birth to an infant with early-onset GBS infec-
tion was 16:1,000 while this probability was 1:1,000
if intrapartum penicillin would have been admin-
istered (incidence 3/1,000 without and 0.2/1,000
with prophylaxis). These figures were derived from
a number of cohort or randomized studies. Costs of
rectovaginal cultures were estimated at $50 and
treatment with ampicillin during labor at $30. The
sum of charges for treatment of one case of early-
onset GBS infection and its sequelae was estimated
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at $67,229 (not including indirect costs). Based on
the above estimates Rouse et al. concluded that the
most optimum strategies for prevention of early-
onset GBS infection were either universal treat-
ment, or treatment based on risk factors, or treat-
ment based on preterm delivery and 36-week
culture status.
The outcome of cost calculations would be dif-
ferent using data from the second period of the
present study. Duration of hospitalization of pre-
term infants was not influenced by the [gresence of
early-onset GBS infection and it is doubtful if costs
were increased in these infants. The incidence of
early-onset GBS infection in term infants was
1/1,000 with a median duration of hospitalization of
9 days and no long-term sequelae. With these data
a screening protocol would not be cost effective.
With adoption of prophylactic strategies against
early-onset GBS infection, an increasing number of
women will receive antibiotics during labor. How-
ever, the consequence of such management on
neonatal sepsis caused by other organisms has not
been well investigated. Four cases were described
with adverse perinatal outcomes from resistant En-
terobacteriaceae after antibiotic usage for either
PROM or positive group B streptococcal cultures. 17
Another study
18 investigated neonatal early-onset
E. coli sepsis before and after implementation of
intrapartum chemoprophylaxis with ampicillin.
This study described 30 infants with E. coli sepsis.
Twelve of 15 infants with an ampicillin-resistant E.
coli had received antepartum ampicillin, while this
occurred only in of 15 infants with an ampicillin-
sensitive strain. Six of the infants with an ampicil-
lin-resistant strain died, while all of the 15 infants
with an ampicillin-sensitive E. coli survived. A pro-
spective study9 of all cases of neonatal sepsis dur-
ing a six-year period, when using chemoprophy-
laxis with ampicillin, described a reduction of
early-onset GBS infection while non-group B strep-
tococcal organisms, especially E. coli, increased.
Both studies support the recent guideline1 for the
use of penicillin instead of ampicillin. Because
penicillin has a narrow spectrum of activity it may
be less likely to select for antibiotic resistant organ-
isms, although conclusive evidence for this is not
available. Resistance of GBS to penicillin has not
been reported, but recently 15% resistance against
clindamycin and 16% resistance against erythromy-
cin was reported,z
Our results demonstrated that early detection of
clinical signs of intrauterine infection and early an-
tibiotic treatment resulted in a statistically signifi-
cant decrease of early-onset GBS infection and re-
duced the serious sequelae of this infection
without large-scale antibiotic administration. Not-
withstanding a reduction of early-onset GBS infec-
tion the incidence of sepsis caused by other organ-
isms remained unchanged. We should be aware
that the prophylactic measures that we take against
early-onset GBS infection might result in an in-
crease of sepsis caused by other pathogens. Insti-
tutions which adopted antibiotic chemoprophylaxis
not only should report on reduced incidence of
early-onset GBS infection, but also should register
all cases of neonatal sepsis and possible changes of
antibiotic resistance of the organisms involved.
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